Katharine A. Van Tassel
Title: Professor of Law and Director, Public Health Law and Science Center (PHLSC) and Health Law Program
Department: School of Law
Selected Works - bepress: http://works.bepress.com/k_vantassel/
Curriculum Vitae: Download in PDF format
Katharine Van Tassel is a Professor of Law and is the Director of the Akron Law’s Public Health Law & Science Center (PHLSC) and its Health Law Certificate Program. She is the recipient of the 2013 Faculty Scholar of the Year award.
Professor Van Tassel clerked for U.S. District Court Judge William K. Thomas before becoming an associate with the international law firm of Squire, Sanders & Dempsey. She began her teaching career in 1997 and has taught Health Law: Quality, Cost and Access, Healthcare Organization and Finance, Government Provision of Healthcare, Bioethics, Public Health Law, Food & Drug Law, Law & Biotechnology, Civil Procedure, Evidence, and Torts. She is the Editor of the Health Law Prof Blog, is a regular blogger on Bill of Health, a blog of the Petrie-Flom Center at the Harvard School of Law, and is a regular blogger on Bio Law: Law and the Life Sciences.
She currently serves on the Executive Board of the Law, Medicine and Healthcare Section of the American Association of Law Schools, on the Executive Board of the Law and Mental Disability Section of the American Association of Law Schools and as the Co-Chair of the Food & Drug Law Committee of the Administrative Law Section of the American Bar Association.
Professor Van Tassel’s scholarship has appeared in such journals as the University of Chicago Legal Forum, the Pepperdine Law Review, the Cardozo Law Review, the Connecticut Law Review, the Brooklyn Law Review, the University of Cincinnati Law Review and the Seton Hall Law Review. She is the author of International Encyclopaedia of Laws: Medical Law, United States of America (Klower, forthcoming, 2015). She is the coauthor of the two-volume treatise Food and Drug Administration (4th ed., forthcoming 2015) which is cited as an authoritative FDA source by the U.S. Supreme Court and numerous circuit and district courts. She is also the co-author on the book Litigating the Nursing Home Case (2nd ed., 2014).
In 2014, Professor Van Tassel was invited by the U.S. Commission on Civil Rights to testify at the 2014 Statutory Enforcement hearings on Patient Dumping in Washington, D.C. Professor Van Tassel offered her insights on how to improve the policies governing the enforcement of the Emergency Medical Treatment and Labor Act ("EMTALA") to better ensure hospitals, localities, or states are not "dumping" patients disabled by a psychiatric medical condition and in need of emergency care.
Professor Van Tassel is a Hearing Officer for medical staff peer review proceedings and is a consultant for matters involving the abuse and neglect of nursing home residents. She has served as a Special Commissioner on the Cervical Cancer Special Commission of the House of Representatives of the Commonwealth of Massachusetts and as a member of both the Clinical Ethics Review Team and the Institutional Review Board for Experimental Drugs and Devices of the largest hospital system in Western Massachusetts.
- Food and Drug Administration (Thomson Reuters 4th ed. forthcoming 2015) (with J.T. O'Reilly)
- The Affordable Care Act and the Modernization of EMTALA - Opening the Door to Innovations in Artificial Intelligence Including Diagnostic Software Using Genetics, Epigenetics, Proteomics and the Microbiome, ___ Hous. J. L. & Health Pol'y ___ (forthcoming 2015)
- International Encyclopaedia of Laws: Medical Law, United States of America (Klower, forthcoming 2015)
- Intellectual Property and Public Health - A White Paper, 7 Akron J. Intell. Prop. ____ (forthcoming 2014) (Ryan Vacca as principal author, with James Ming Chen, Jay Dratler, Thomas Folsom, Timothy S. Hall, Yaniv Heled, Frank A. Pasquale, Elizabeth Reilly, Jeffrey Samuels, Katherine Strandburg, Kara W. Swanson and Andrew W. Torrance)
- Litigating the Nursing Home Case (ABA Press 2nd ed. 2014) (with J.T. O'Reilly)
- Harmonizing the Affordable Care Act with the Three Main National Systems for Healthcare Quality Improvement: The Tort, Licensure and Hospital Peer Review Systems, 78 Brook. L. Rev. 1 (2013)
- Using Clinical Practice Guidelines and Knowledge Translation Theory to Cure the Negative Impact of the Hospital Peer Review Hearing System on Health Care Quality, Cost, and Access, 40 Pepp. L. Rev. 911 (2013)
- Regulating in Uncertainty: Animating the Public Health Product Safety Net to Capture Consumer Products Regulated by the FDA that Use Innovative Technologies, Including Nanotechnologies, Genetic Modification, Cloning, and Lab Grown Meat, 2013 U. Chi. Legal F. 101 (2013)
- Blacklisted: The Constitutionality of the Federal System for Publishing Reports of 'Bad Doctors' in the National Practitioner Data Bank, 33 Cardozo L. Rev. 101 (2012)
- The Growing Consumer Exposure to Nanotechnology in Everyday Products: Regulating Innovative Technologies in Light of Lessons from the Past, 44 Conn. L. Rev. 481 (2012) (with R. Goldman)
- Genetically Modified Food, Risk Assessment and Scientific Uncertainty Principles: Does the New Understanding of the Networked Gene Trigger The Need For Post-Market Surveillance to Protect Public Health?, 15 B.U. J. Sci. & Tech. L. 220 (2009)
- Slaying the Hydra: The History of Quack Medicine, the Obesity Epidemic and the FDA's Battle to Regulate Dietary Supplements, 6 Indiana Health L.J. 204 (2009)
- Hospital Peer Review Standards and Due Process: Moving From Tort Theories To Contract Principles Based on Clinical Practice Guidelines, 36 Seton Hall L. Rev. 1179 (2006)
- Legal and Ethical Aspects of Healthcare, 16 The Law and Courts Section, The American Political Science Foundation 306 (2006)
- The Introduction of Biotech Foods to the Tort System: Creating a New Duty To Identify, 72 U. Cinn. L. Rev. 1645 (2004)